CEO SUMMARY: Will implementation of the final PAMA private payment rate reporting rule for labs put smaller, community labs at financial risk? Yes, says the National Independent Laboratory Association (NILA). By deliberately setting a standard to exclude private payer payment data from hospital outpatient and outreach labs that receive payments off the CLFS, CMS will […]
PAMA Final Rule a Threat To Community Lab Survival
Excluding small lab payments means CMS may set lower rates that favor only larger labs
- By Joseph Burns
- > From the Volume XXIII No. 9 - July 5, 2016 Issue
- Tags: cap, Capitation, clfs, clinical diagnostic laboratory, clinical lab, clinical laboratories, Clinical Laboratory, Clinical Laboratory Fee Schedule, clinical laboratory test, clinical laboratory testing, clinical laboratory testing market, clinical laboratory tests, clinical labs, competitive bid, diagnostic lab, diagnostic laboratory, diagnostic laboratory tests, hie, hospital laboratories, hospital laboratory, lab executive, lab test, lab testing, lab testing services, lab tests, labcorp and quest, laboratories, laboratory association, laboratory companies, laboratory fee schedule, laboratory test, laboratory testing, laboratory tests, labs tests, Medicare, Medicare Part B, national independent laboratory association, outreach lab, outreach laboratory, pathologists, private payer, the clinical laboratory, the laboratory
